[A NEW APPROACH TO TREATMENT LIVER CIRRHOSIS IN CONNECTION WITH INTESTINAL DYSBIOSIS].
In order to increase the effectiveness of treatment of the liver cirrhosis were examined 65 patients, we studied the effect on the features flow of intestine microbiocenosis and were are included to the combined treatment the synbiotic medications "Bifilakt extra". Inclusion to the combined treatment of the examined patients with liver cirrhosis synbiotic medications "Bifilakt extra" probably led to better reduction of subjective and objective signs of cirrhosis and intensity of functional biochemical syndromes, symptoms of hepatic encephalopathy.
I M
IM
Gavrysh
L V
LV
Glushko
D000437:Alcoholism / Q000150:complications; D004359:Drug Therapy, Combination; D064806:Dysbiosis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005260:Female; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D007410:Intestinal Diseases / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D008104:Liver Cirrhosis, Alcoholic / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D058616:Synbiotics / Q000008:administration & dosage*